|
Adipokines | Osteogenic | Osteoclastic | Relationship with BMD |
|
Adiponectin | Promotes the MSCs osteogenesis and osteoblast maturation [4–8] | Inhibits the osteoclastogenesis and osteoclastic activity [8–10] | Negative related with the BMD; a predictor of osteoporotic fractures in certain population [10–12, 59–63] |
|
Leptin | Stimulate osteogensis both in vitro studies and subcutaneous injection animal model [13, 64–69] | Inhibits the osteoclastogenesis and osteoclastic activity [14–17, 70, 71] | No relationship was found after adjust for age, gender and hormone [11, 18–36] |
|
Resistin | Stimulates proliferation and weakly promotes the osteoblasts maturation [37] | Strongly increases the number and activity of osteoclast [37] | Negative related with certain population [10, 24] |
|
Visfatin | Stimulates human osteoblast proliferation, maturation, and mineralization [38, 39] | Inhibits the formation of osteoclast [40] | No relationship was found [24, 33, 41, 42] |
|
Vaspin | Inhibits the apoptosis of osteoblast [43] | No paper published | No paper published |
|
Chemerin | Negative effect by greatly promoting the adipogenesis of the MSCs [44] | No paper published | No paper published |
|
Omentin-1 | Inhibits the osteoblastic differentiation [45] | No paper published | Not clear, need more data [42, 72] |
|